Clinical Trial Update: The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. [Phase 4]

View source ↗

Summary

Phase 4 trial investigating secondary benefits of a prostaglandin analog in Thyroid Eye Disease was withdrawn; the study also referenced ocular hypertension and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Thyroid Eye Disease

Snippet

Sponsor: Stanford University | Conditions: Thyroid Eye Disease, Ocular Hypertension | Phase 4 | Status: WITHDRAWN